share_log

CVS Health | SC 13G: Statement of acquisition of beneficial ownership by individuals-Dodge & Cox(5.0%)

CVS Health | SC 13G: Statement of acquisition of beneficial ownership by individuals-Dodge & Cox(5.0%)

西维斯健康 | SC 13G:超过5%持股股东披露文件-Dodge & Cox(5.0%)
美股SEC公告 ·  2024/11/13 12:03

Moomoo AI 已提取核心信息

On September 30, 2024, investment firm Dodge & Cox filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 5.0% ownership stake in CVS Health Corporation, amounting to 63,030,690 shares. The filing indicates that Dodge & Cox has sole voting power over 59,793,915 shares and sole dispositive power over all 63,030,690 shares. The investment advisor, registered under section 203 of the Investment Advisors Act of 1940, asserts that the acquisition of these shares is part of its ordinary course of business and not intended to change or influence control of CVS Health. The filing was certified as true and correct by Katherine M. Primas on behalf of Dodge & Cox on November 13, 2024.
On September 30, 2024, investment firm Dodge & Cox filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 5.0% ownership stake in CVS Health Corporation, amounting to 63,030,690 shares. The filing indicates that Dodge & Cox has sole voting power over 59,793,915 shares and sole dispositive power over all 63,030,690 shares. The investment advisor, registered under section 203 of the Investment Advisors Act of 1940, asserts that the acquisition of these shares is part of its ordinary course of business and not intended to change or influence control of CVS Health. The filing was certified as true and correct by Katherine M. Primas on behalf of Dodge & Cox on November 13, 2024.
2024年9月30日,投资公司道奇与考克(Dodge & Cox)向美国证券交易委员会提交了13G表格,披露其拥有CVS健康公司5.0%的股份,共计63030690股。报告显示道奇与考克对59793915股拥有唯一的表决权,对所有63030690股拥有唯一的处分权。根据1940年投资顾问法第203条注册的投资顾问声称,收购这些股份是其正常业务的一部分,不打算改变或影响对CVS健康的控制。该申报由道奇与考克代表Katherine m. Primas在2024年11月13日证实属实。
2024年9月30日,投资公司道奇与考克(Dodge & Cox)向美国证券交易委员会提交了13G表格,披露其拥有CVS健康公司5.0%的股份,共计63030690股。报告显示道奇与考克对59793915股拥有唯一的表决权,对所有63030690股拥有唯一的处分权。根据1940年投资顾问法第203条注册的投资顾问声称,收购这些股份是其正常业务的一部分,不打算改变或影响对CVS健康的控制。该申报由道奇与考克代表Katherine m. Primas在2024年11月13日证实属实。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息